Show simple item record

dc.contributor.authorWilliams, Monray Edward
dc.contributor.authorFielding, Burtram Clinton
dc.date.accessioned2021-10-13T11:48:59Z
dc.date.available2021-10-13T11:48:59Z
dc.date.issued2021
dc.identifier.citationWilliams, M. E., & Fielding, B. C. (2021). Insult to injury-potential contribution of Coronavirus disease-19 to neuroinflammation and the development of HIV-associated neurocognitive disorders. AIDS Research and Human Retroviruses, 37(8), 601–609. https://doi.org/10.1089/aid.2020.0136en_US
dc.identifier.issn1931-8405
dc.identifier.uri10.1089/aid.2020.0136
dc.identifier.urihttp://hdl.handle.net/10566/6901
dc.description.abstractHIV-associated neurocognitive disorders (HAND) are consequences of the effects of HIV-1 within the central nervous system (CNS).1,2 HAND are classified according to impairment severity, namely, asymptomatic neurocognitive impairment, mild neurocognitive impairment, or HIV-associated dementia.3,4 In the modern antiretroviral therapy (ART) era, the more severe forms of HAND have significantly decreased, however, milder forms are persisting in 50% of people living with HIV (PLWH).5 Currently, the underlying neuropathophysiological mechanisms of HAND remain unclear. However, the common hypothesis for the persistence of HAND in the modern ART era is the continued immune activation and low-grade inflammation experienced by PLWH.en_US
dc.language.isoenen_US
dc.publisherMary Ann Lieberten_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirusesen_US
dc.subjectHIVen_US
dc.subjectNeurocognitive disordersen_US
dc.subjectInflammationen_US
dc.titleInsult to injury-potential contribution of Coronavirus disease-19 to neuroinflammation and the development of HIV-associated neurocognitive disordersen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record